Pfizer

King’s College London has announced that it has recently entered into an exclusive license agreement with Pfizer Inc. for the development of a series of adeno-associated virus (AAV) gene therapy vectors

In the biggest sign yet that the era of blockbuster drug is drawing to a close, Pfizer this week announced the creation of a new research unit focused on rare diseases.

Pfizer is to invest over €11 million in setting up an R&D Technology Laboratory at its Ringaskiddy site in Cork, Ireland.

GlaxoSmithKline (GSK) and Pfizer are spinning out all HIV/AIDS-related R&D and marketed drugs into a separate, jointly-controlled company.

Corporate incubators bridge the seed funding gap, but apart from pocket money what can start-ups learn from their foster parents?